CHI Director Prof Karen Sliwa and collaborators contributed to the STRONG study, published in The Lancet, Monday 7th November

STRONG-HF study, suggested that rapid up-titration of guideline-directed medical therapy (GDMT) after an acute heart failure (AHF) admission led to a reduction in the 180-day risk of HF readmission or death, and greater improvement in quality of life compared with usual care.  The full paper is available here